Cyclacel Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CYCC and buy or sell other stocks, ETFs, and their options commission-free!

About CYCC

Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. 

CEO
Spiro Rombotis
CEOSpiro Rombotis
Employees
12
Employees12
Headquarters
Berkeley Heights, New Jersey
HeadquartersBerkeley Heights, New Jersey
Founded
1996
Founded1996
Employees
12
Employees12

CYCC Key Statistics

Market cap
4.06M
Market cap4.06M
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
54.73K
Average volume54.73K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$1.02
52 Week high$1.02
52 Week low
$0.2813
52 Week low$0.2813

People also own

Based on the portfolios of people who own CYCC. This list is generated using Robinhood data, and it’s not a recommendation.
Tonix Pharmaceuticals
Tilray Brands
Faraday Future Intelligen…
AMC Entertainment
Mullen Automotive
Plug Power
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.